MASSACHUSETTS SOCIETY OF CLINICAL ONCOLOGISTS INC (EIN 042863899) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1985

Legal Domicile

Principal Officer

MICHAEL CONSTANTINE

Phone

7814347314

Tax Period

2024-04-01 to 2025-03-31

MASSACHUSETTS SOCIETY OF CLINICAL ONCOLOGISTS INC, founded in 1985, is a small nonprofit that reported $320K in total revenue in fiscal year 2024. Revenue decreased 15% compared to the prior year. The organization ran a surplus of $74K, a strong 23% operating margin.

Mission

TO DISSEMINATE INFORMATION CONCERNING THE DIAGNOSIS, CARE, AND THE TREATMENT OF CANCER TO PRACTICING PHYSICIANS AND THE GENERAL PUBLIC.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $313,000

Program Service Revenue $6,400

Investment Income $212

Other Revenue $0

TOTAL REVENUE $319,612

Expense Breakdown

Grants Paid $101,305

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $225,843

Other Expenses $144,279

TOTAL EXPENSES $245,584

Year-over-Year Comparison

	2024	2023	Change
Revenue	$319,612	$378,027	-0.2%
Expenses	$245,584	$196,505	+0.2%
Net Income	$74,028	$181,522	-0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MEGHAN SHEA	SECRETARY	2.00	Officer	$0	$0	$0
MICHAEL CONSTANTINE	PRESIDENT	2.00	Officer	$0	$0	$0
OMAR ETON	DIRECTOR	1.00	Director	$0	$0	$0
LARISSA NEKHLYUDOV	DIRECTOR	1.00	Director	$0	$0	$0
CLAIRE FUNG	DIRECTOR	1.00	Director	$0	$0	$0
KALA SEETHARAMAN	PAST PRESIDENT	2.00	Officer	$0	$0	$0
INGA LENNES	DIRECTOR	1.00	Director	$0	$0	$0
JEFFREY WISCH	DIRECTOR	1.00	Director	$0	$0	$0
ERIC T WONG	DIRECTOR	1.00	Director	$0	$0	$0
EDRESS OTHMAN	DIRECTOR	2.00	Officer	$0	$0	$0
TARA SOUMERAI	DIRECTOR	1.00	Director	$0	$0	$0
DAVIS SHEPRO	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$319,612	$245,584	$1,440,445	$74,028
2024	$378,027	$196,505	$1,366,416	$181,522
2023	$298,271	$259,482	$1,184,896	$38,789
2022	$245,160	$235,958	$1,146,107	$9,202
2021	$155,158	$77,264	$1,136,905	$77,894
2020	$325,146	$146,256	$1,059,011	$178,890
2018	$228,623	$151,517	$798,126	$77,106

MASSACHUSETTS SOCIETY OF CLINICAL ONCOLOGISTS INC